Trial Profile
The Effects of ADHD Medication (TEAM) Study: Neurobehavioral Effects of Abrupt Methylphenidate Discontinuation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2023
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms TEAM
- 14 Jul 2021 Status changed from recruiting to completed.
- 14 Apr 2020 Planned primary completion date changed from 1 Jun 2019 to 1 Jun 2020.
- 26 Jan 2016 Planned End Date changed from 1 Jan 2020 to 1 Jun 2020, as reported by ClinicalTrials.gov.